Investors Snatch ADMS Even Lower Than Its Secondary Stock Offering
January 25, 2018 at 10:42 AM EST
Looking back to 2 days ago, Adamas Pharmaceuticals Inc (ADMS) priced a 3,000,000 share secondary stock offering at $41.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..